Nexalin Technology, Inc. (NXL) intrinsic value & 10-year financials
Nexalin Technology, Inc. (NXL) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 6 fiscal years revenue grew 20.3% a year to $301.6K, with an average return on invested capital of -75.5%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $2.35
- Market cap
- $38.5M
- Revenue (FY2025)
- $301.6K
- Revenue growth (6-yr CAGR)
- 20.3%
- ROIC (10-yr avg)
- -75.5%
- Free cash flow (FY2025)
- —
NXL 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $301.6K | -$8.2M | -$0.50 | — | -2781.7% | -221.5% |
| FY2024 | $168.7K | -$7.6M | -$0.83 | — | -4596.1% | -221.1% |
| FY2023 | $110.7K | -$4.6M | -$0.63 | — | -5143.5% | -87.4% |
| FY2022 | $1.3M | -$1.7M | -$0.30 | — | -138.7% | -112.2% |
| FY2021 | $144.1K | -$6.1M | — | — | -4177.7% | 264.9% |
| FY2020 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Nexalin Technology, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Nexalin Technology, Inc. has historically struggled to out-earn its cost of capital, averaging just -40.3% ROIC.
Nexalin Technology, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Nexalin Technology, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-16.61 per share.